** Lenacapavir: a promise to prevention in financial uncertainty **
The Global Fund initiative for HIV, tuberculosis and malaria marks a promising advance with the expected deployment of Lenacapavir, a biannual injection with impressive results in HIV prevention. For low -income countries like South Africa, this innovation signals a glimmer of hope, but its success will strongly depend on the financial support of the PEPFAR, whose future remains uncertain in the face of political changes. The prophylactic pre-exhibition represents a leap forward compared to traditional methods, but the fragility of funding exposes global health programs to critical risks.
Despite the financial challenges, Peter Sands’ argument on the importance of investing in health as an economic lever attracts attention. A dollar invested in health could generate up to 19 dollars in returns, highlighting the urgency of a reconfiguration of help models. While the Global Fund calls for a commitment of $ 18 billion, international solidarity becomes essential to save millions of lives by 2029, while redefining our collective approach to the world health crises.